CLL Pharma S.A. (Synt:em)

BrainCells (BCI)

This biopharmaceutical company develops neurogenic compounds to treat central nervous system diseases for patients with psychiatric and neurological disorders.

EnClear Therapies

The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

BrainZell

The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.

Travin

This company develops blood-brain barrier shuttles for RNA therapeutics to enable the treatment of neurological diseases.

Neuro3D SA

This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

Synendos Therapeutics

This company develops small molecule inhibitors to treat patients with central nervous system disorders, such as anxiety and post-traumatic stress disorder.